Ultrasensitive Blood Test Predicts Recurrence and Survival After Treatment for Head and Neck Cancer
Read Full Article
#HeadAndNeckCancer #LiquidBiopsy #CancerRecurrenceSurvival
Read Full Article
#HeadAndNeckCancer #LiquidBiopsy #CancerRecurrenceSurvival
Mass General Brigham
Ultrasensitive Blood Test Predicts Recurrence and Survival After Treatment for Head and Neck Cancer
HPV-DeepSeek shows promise for more personalized post-operative treatment plans by identifying patients who may benefit from additional treatment.